← All companies

ONCY

Oncolytics Biotech Inc.

ONCY Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.81

+0.03 +3.97%

Key statistics

from XBRL data in SEC filings

Market cap

$96.8M

Revenue (TTM)

—

Net income (TTM)

-$28.8M

EPS (TTM)

$-0.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$20.1M

Cash

$5.49M

Total assets

$8.16M

Gross margin

—

52-week range

$0.73 – $1.51

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Delisting notice or listing-rule failure Jul 24, 2026 8-K Other events Jul 20, 2026 8-K Other events Jul 13, 2026 8-K Changed accountants Jul 8, 2026 8-K Other events Jun 16, 2026 8-K Director or officer change; Other events Jun 2, 2026 8-K Other events Jun 1, 2026 8-K Other events May 22, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Other events May 4, 2026 8-K Other events Apr 27, 2026 8-K Other events Apr 6, 2026 8-K Other events Apr 6, 2026 8-K Entered a material agreement; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Modified rights of security holders; Amended charter or bylaws Mar 20, 2026 8-K Other events Mar 19, 2026 8-K Other events Mar 2, 2026 8-K Other events Feb 24, 2026 8-K Other events Feb 4, 2026 8-K Shareholder vote results Jan 15, 2026 8-K Other events Jan 15, 2026 8-K Other events Jan 12, 2026 6-K Jan 7, 2026 6-K Dec 16, 2025 6-K Dec 10, 2025 6-K Nov 20, 2025 6-K Nov 19, 2025 6-K Nov 12, 2025 6-K Nov 4, 2025 6-K Oct 28, 2025 6-K Oct 20, 2025 6-K FORM 6-K Oct 20, 2025 6-K FORM 6-K Oct 10, 2025 6-K Sep 29, 2025 6-K Sep 16, 2025 6-K Sep 8, 2025 6-K Sep 2, 2025 6-K Aug 28, 2025 6-K Aug 11, 2025